Suppr超能文献

DEN和CCl4诱导的纤维化及炎症相关肝细胞癌小鼠模型

The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.

作者信息

Uehara Takeki, Pogribny Igor P, Rusyn Ivan

机构信息

Department of Environmental Sciences and Engineering, University of North Carolina, Chapel Hill, North Carolina.

Strategic Development Department, Shionogi & Co, Osaka, Japan.

出版信息

Curr Protoc Pharmacol. 2014 Sep 2;66:14.30.1-14.30.10. doi: 10.1002/0471141755.ph1430s66.

Abstract

Human hepatocellular carcinoma (HCC) develops most often as a complication of fibrosis or cirrhosis. While most human studies of HCC provide crucial insights into the molecular signatures of HCC, seldom do they address the etiology of HCC. Mouse models are essential tools for investigating the pathogenesis of HCC; however, the overwhelming majority of cancer models in rodents do not feature liver fibrosis. Detailed in this unit is a protocol for an experimental mouse model of HCC that arises in association with advanced liver fibrosis. The disease model is induced by a single injection of N-nitrosodiethylamine (DEN) followed by repeated administration of carbon tetrachloride (CCl4 ). A dramatic potentiation of liver tumor incidence is observed following administration of DEN and CCl4 , with 100% of mice developing liver tumors at 5 months of age. This model can be employed for studying the molecular mechanisms of fibrogenesis and HCC development, and in cancer hazard/chemotherapy testing of drug candidates.

摘要

人类肝细胞癌(HCC)最常作为纤维化或肝硬化的并发症出现。虽然大多数关于HCC的人体研究为HCC的分子特征提供了关键见解,但它们很少涉及HCC的病因。小鼠模型是研究HCC发病机制的重要工具;然而,绝大多数啮齿动物癌症模型没有肝纤维化特征。本单元详细介绍了一种与晚期肝纤维化相关的HCC实验小鼠模型的方案。该疾病模型通过单次注射N-亚硝基二乙胺(DEN),随后反复给予四氯化碳(CCl4)诱导。在给予DEN和CCl4后,观察到肝肿瘤发生率显著升高,100%的小鼠在5月龄时发生肝肿瘤。该模型可用于研究纤维化形成和HCC发展的分子机制,以及候选药物的癌症风险/化疗测试。

相似文献

1
The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.
Curr Protoc Pharmacol. 2014 Sep 2;66:14.30.1-14.30.10. doi: 10.1002/0471141755.ph1430s66.
3
Proteomic analysis of DEN and CCl-induced hepatocellular carcinoma mouse model.
Sci Rep. 2024 Apr 5;14(1):8013. doi: 10.1038/s41598-024-58587-6.
4
Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.
J Cancer Res Clin Oncol. 2017 May;143(5):821-834. doi: 10.1007/s00432-017-2364-z. Epub 2017 Feb 25.
6
9
Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.
Int J Cancer. 2014 Jun 15;134(12):2778-88. doi: 10.1002/ijc.28610. Epub 2013 Dec 14.
10
TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
PLoS One. 2016 Jul 8;11(7):e0158819. doi: 10.1371/journal.pone.0158819. eCollection 2016.

引用本文的文献

1
The application of liver cancer organoids in tumour precision medicine: A comprehensive review.
ILIVER. 2025 Jul 5;4(3):100179. doi: 10.1016/j.iliver.2025.100179. eCollection 2025 Sep.
2
Intratumor sp. drives DEN-induced hepatocellular carcinoma progression by modulating gut microbiota and angiogenesis.
Curr Res Microb Sci. 2025 Jun 24;9:100428. doi: 10.1016/j.crmicr.2025.100428. eCollection 2025.
4
6
Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response.
J Pathol. 2025 Apr;265(4):502-517. doi: 10.1002/path.6403. Epub 2025 Feb 24.
7
Liver sinusoidal endothelial cells regulate the balance between hepatic immunosuppression and immunosurveillance.
Front Immunol. 2025 Jan 17;15:1497788. doi: 10.3389/fimmu.2024.1497788. eCollection 2024.
10
Rifaximin prophylaxis in MASLD‑hepatocellular carcinoma: Lessons from a negative animal model.
Biomed Rep. 2024 Oct 24;22(1):4. doi: 10.3892/br.2024.1882. eCollection 2025 Jan.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验